Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
7.77%EBITDA Margin
VS
Market
Sector
Industry
History
$ 6.49Close
$ 3.79 - $ 11.7 52-Week Range
Ticker Information
Ticker
CSBRCompany Name
CHAMPIONS ONCOLOGY INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCHAMPIONS ONCOLOGY INC - EBITDA Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CSBR - EBITDA % Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 4.42M | 7.77% | $ 56.88M |
| 3/31/2025 | $ 6.27M | 11% | $ 56.94M |
| 12/31/2024 | $ 8.1M | 13.83% | $ 58.59M |
| 9/30/2024 | $ 1.15M | 2.15% | $ 53.57M |
| 6/30/2024 | $ -1.56M | -3.03% | $ 51.66M |
| 3/31/2024 | $ -5.44M | -10.85% | $ 50.16M |
| 12/31/2023 | $ -7.67M | -15.57% | $ 49.22M |
| 9/30/2023 | $ -7.47M | -14.95% | $ 49.98M |
| 6/30/2023 | $ -5.34M | -10.14% | $ 52.69M |
| 3/31/2023 | $ -3.02M | -5.61% | $ 53.87M |
Key Performance Insights, Last 5 Years
- CHAMPIONS ONCOLOGY INC's latest trailing twelve months (TTM) EBITDA % stands at -1.02%.
- Over the past 5 years, CHAMPIONS ONCOLOGY INC's average EBITDA % has been 0.01%.
- The median EBITDA % for CHAMPIONS ONCOLOGY INC during this period was 2.73%
- CHAMPIONS ONCOLOGY INC reached its highest EBITDA % over the past 5 years at 13.83%.
- The lowest EBITDA % recorded by CHAMPIONS ONCOLOGY INC in the same timeframe -15.57%
CHAMPIONS ONCOLOGY INC's EBITDA % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA % Benchmarks
Similar metrics to Revenues:
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
Definition of EBITDA Margin
[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.EBITDA / Revenues
(=) EBITDA % EBITDA % for CHAMPIONS ONCOLOGY INC is calculated as follows: EBITDA [ $ -383K ] / Revenues [ $ 37.42M ]
(=) EBITDA % [ -1.02% ] CSBR - EBITDA Margin, Last 5 years
-15.57%
Minimum
Dec 31, 2023
13.83%
Maximum
Dec 31, 2024
0.01%
Average
2.73%
Median
EBITDA % Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.12% with a standard deviation of 26.88%.
The following table provides additional summary stats:
EBITDA % in the Market:
| filtered constituents | 3.29K |
|---|---|
| min | -75.07% |
| max | 97.73% |
| average | 16.12% |
| median | 14.72% |
| std | 26.88% |